Xianyu Zhu
Papers
1
Total Citations
35
H-Index
1
About
Dr. Xianyu Zhu is a pioneering researcher at the forefront of nanomedicine and biomaterials, with a focused expertise in the biomedical applications of gallium-based liquid metals. His most cited work, "Transformable Gallium‐Based Liquid Metal Nanoparticles for Tumor Radiotherapy Sensitization" (2022, 35 citations), represents a landmark contribution to cancer therapy. In this study, Dr. Zhu was the first to demonstrate the use of nanosized gallium-indium alloys as transformable radiosensitizers, exploiting the unique phase-change properties of liquid metals to enhance the efficacy of radiotherapy. This innovative approach addresses a critical challenge in oncology—improving tumor sensitivity to radiation while minimizing damage to healthy tissues. By engineering nanoparticles that can dynamically respond to the tumor microenvironment, Dr. Zhu has opened a new frontier in theranostic platforms. His work bridges materials science and clinical oncology, offering a transformative strategy for precision cancer treatment. With his groundbreaking research, Dr. Zhu is establishing himself as a rising leader in the development of next-generation nanotherapeutics, poised to make a lasting impact on both fundamental science and translational medicine.
Research Focus
Key Achievements
Top Papers
- 1